Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05204290 · ClinicalTrials.gov registry record · Early Phase 1
Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab
A Early Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT05204290 is a Early Phase 1 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 1 participants.
The verdict
NCT05204290, a Early Phase 1 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out what effects (good and bad) Pembrolizumab and radiosurgery have on participants with high-grade epidural disease of the spine.
Interventions
- DRUG Pembrolizumab
- RADIATION Stereotactic Body Radiation Therapy
- OTHER Blood draws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2022-10-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05204290
The ClinicalTrials.gov registry entry for NCT05204290 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pembrolizumab is the first listed.
NCT05204290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05204290 about?
NCT05204290 is a clinical study titled "Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab". The purpose of this research study is to find out what effects (good and bad) Pembrolizumab and radiosurgery have on participants with high-grade epidural disease of the spine.
What is the current status of trial NCT05204290?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2022-03-28. Estimated completion is 2022-10-07.
What interventions are being tested in trial NCT05204290?
The interventions under investigation include: Pembrolizumab (DRUG), Stereotactic Body Radiation Therapy (RADIATION), Blood draws (OTHER).
Who is sponsoring clinical trial NCT05204290?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.